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Patients with CF have an impaired ability to absorb fats from the gastrointestinal tract, as a consequence of their reduced secretion of pancreatic enzymes (12) . A repercussion of this is a deficiency of the principal fat-soluble antioxidant vitamin E (1 3, 14) . In addition, deficiencies of other circulating antioxidants, such as ferritin and serum albumin, have been reported in CF patients (15, 16) . Children with CF are also deficient in selenium (14, 17) , which is essential for the activity of the antioxidant enzyme glutathione peroxidase (1 8) . Glutathione peroxidase activities in CF patients have, however, been reported to be normal (19) . It has been suggested that combined selenium and vitamin E deficiencies in CF patients attaining adulthood may contribute to the development of cancers (14) . Activity of superoxide dismutase and catalase in erythrocytes of CF patients has been shown to be elevated, indicating that these individuals may be undergoing an intracellular oxidative stress (20) . This hypothesis is supported by studies of lipid peroxidation markers in CF patients (2 1-23) . Evidence for an extracellular oxidant/antioxidant imbalance has been observed in the lunes of Young, adults -. -with CF (24, 25) .
The transient existence of free-radical species makes it impractical to measure them in vivo, so most studies focus on their damaging effects on cellular components, notably the peroxidation of polyunsaturated fatty acids (5). In 1985, Wayner et al. (26) developed the total TRAP assay. This assay requires only a small sample of plasma and measures the subject's capacity to buffer a sample of linoleic acid against peroxidation, using a heat-labile initiator ABAP as a source of free radicals. The peroxidation of linoleic acid is followed as a decrease in the free oxygen content of the sample in a Clark cell.
In the present study, the TRAP assay was used to investigate the proposal that CF patients may have a decreased capacity to withstand free-radical stress as a consequence of their reported antioxidant deficiencies.
Free radical species have been implicated in the etiology of a SUBJECTS AND METHODS healthy children or patients with CF. CF patients were attending the CF clinic at Southampton General Hospital for a regular checkup and were not presenting with specific problems. The mean age of the CF group was 8 y 4 mo ( n = 24, age range 2-18 y). The control group used in the study was a group of healthy children attending Southampton General Hospital or outpatient clinics for minor surgical procedures (Table 1 ) with a mean age of 7 y and 1 I mo ( n = 2 1, age range 2-17 y). Ethical permission for this study was obtained from the Joint Ethical Subcommittee, Southampton and South West Hampshire Health Authority.
Sample handling. Heparinized blood samples from CF patients and controls were centrifuged at 2000 rpm, 4"C, for 10 min.
Plasma was stored at -20°C for up to 6 wk before assays. TRAP activity and antioxidant concentrations were stable over this period.
Determination of TRAP activity. TRAP was determined using a modification of the method of Wayner et al. (26) . One hundred pL of plasma were mixed with 10 pL of linoleic acid in a glass vial by vortexing for approximately 30 s. Fifty pL of the plasmalinoleic acid mixture were added to a Perspex oxygen electrode cell (Rank Brothers, Bottisham, UK), containing 3 mL of PBS, pH 7.5, and 30 pL of 0.4 M ABAP, at 37°C. Light was excluded from the cell to prevent photodecomposition of the ABAP. Oxygen loss from the cell, representing oxygen uptake during the peroxidation of the linoleic acid, was followed until the rate of loss was maximal. At this point, 25 pL of 0.4 mM Trolox C were added.
The experimentally measured value of TRAP (TRAP,,,,) was calculated from the equation:
where Ri is the rate of peroxyl radical generation from the decomposition of ABAP at 37°C and T,I,,,, and T T~~I~~ are the respective lengths of the induction periods during which the plasma antioxidants or Trolox C buffers against the maximal rate of oxygen loss (Fig. 1) .
Determination of vitamin E. One hundred pL of plasma were extracted with 100 pL of anhydrous HPLC grade ethanol and 400 pL of HPLC grade hexane. a-Tocopherol acetate was added as an internal standard. The hexane layer was removed and evaporated to dryness under a stream of nitrogen. The extract was redissolved in 400 pL of HPLC grade methanol, and 100 pL aliquots were analyzed by HPLC. A 7 X 100 mm, 5-pm C18 column (Jones Chromatography, Hengoed, UK) was eluted with methano1:water (39:l vol/vol), at a flow rate of 0.8 mL/min. Detection was by UV absorbance at 292 nm (27) .
Determination of vitamin C and uric acid. The HPLC determination of uric acid and ascorbate in plasma was based upon the method of Iriyama et al. (28) . One hundred pL of plasma were extracted with 400 pL 2% metaphosphoric acid and 100 pL HPLC grade heptane. Samples were vortex-mixed for 40 s and then centrifuged at 13 000 x g for 5 min. Twenty-pL aliquots were injected for HPLC analysis. A 10 x 300 mm, 5-pm C18 column (Jones Chromatography) was eluted with a 0.2 M The stoichiometric factor for the interaction of ascorbate with free radicals has been shown to vary with the concentration of ascorbate (32) (33) (34) . Accordingly, the value of x was taken from a sliding scale, in which x = 2 at an ascorbate concentration of 1 pmol/L and x = 0.3 at 100 pmoi/L (32).
In vivo ascorbute loading experiment. Ten normal, healthy adult volunteers provided a sample of 5-10 mL of venous blood 5 min before drinking a 10-mL solution containing 1.5 g of ascorbic acid or sucrose (control). Three h later, a second blood sample was taken. TRAP activity and plasma ascorbate status were determined in both baseline and postloading samples.
Statistical analysis. Data are presented as median values with ranges. Statistical analysis was performed using the Mann-Whitney U test for nonparametric data. Calculation of correlation coefficients were made using a linear regression analysis program. Table 2 shows the plasma concentrations of the four antioxidants studied, in children with CF and in age-matched controls. dren with CF. They ranged from 33.7 to 850.5 pmol/L, with I I of the 24 patients having plasma ascorbate levels greater than the normal reported range (>I00 pmol/L). Plasma uric acid concentrations (Table 2) were similarly elevated in patients with CF. Nineteen of 21 control children had plasma urate levels within the reported range of 40 to 440 pmol/ L (35), the levels of the other two individuals being only marginally higher (502 and 547 pmol/L). CF patients had plasma urate levels ranging from 59 to 1494 pmol/L, and although the median concentration was within normal ranges, 10 of 22 individuals had higher than normal urate concentrations.
RESULTS
Vitamin E concentrations (Table 2) were similar in control children and CF patients. In controls, vitamin E levels ranged from 14.16 to 24.46 pmol/L, whereas levels of CF patients were more widely distributed from 8.55 to 35.60 pmol/L. A number of the CF patients (9 of 18) were found to have vitamin E levels at the lower end of the normal range.
Plasma sulfhydryl concentrations were significantly increased in children with CF (Table 2) . Control children had sulfhydryl levels ranging from 270.6 to 577.2 pmol/L, whereas in CF patients the range was 3 19.1 to 1 162.0 pmol/L. TRAP,,,, activities are shown in Table 3 . TRAP,,,, in CF patients was significantly lower (16%) than in controls. TRAPcaI, were, however, greater in CF patients than in controls (not significant). TRAP,,,, and TRAPcaI, values were similar in controls, giving a low value for TRAPdiK. In CF patients, the discrepancy between TRAP,,,, and TRAP,,,, was greater; hence TRAPdiffwas significantly higher in this group than in controls. TRAPd,r was found to correlate strongly with plasma ascorbate concentrations among the CF patients (r = 0.801, p < 0.00001) but not in the age-matched control group (r = -0.160, NS).
To further investigate the influence of ascorbate on TRAP,,,,, a series of eight healthy adult volunteers were orally administered 1.5 g of ascorbic acid, 5 min after a blood sample was taken. Three h later, a second blood sample was taken and the TRAP,,,, and plasma ascorbate levels in the two blood samples were compared (Table 4) . Two control adults who were administered a solution of sucrose showed no change in TRAP,,,, over the 3-h period. In this period, the mean plasma ascorbate concentration of those individuals receiving ascorbate increased from 42.5 
DISCUSSION
The data obtained in this study indicate that some of children with CF have elevated concentrations of three plasma antioxidants: ascorbic acid, uric acid, and sulfhydryl groups. Plasma vitamin E concentrations in the majority of CF patients were similar to those of age-matched controls. This particular finding was not surprising, as vitamin E status of CF patients attending the outpatients clinic at Southampton has been monitored over the past 5 y and supplements have been recommended where necessary. This approach has led to a normalization of plasma vitamin E concentrations in CF patients over this period.
The major surprise of this study was the elevated levels of the other antioxidants assessed. Plasma uric acid concentrations of 59 to 1494 pmol/L were observed; these were significantly higher than urate concentrations in controls. Normal plasma urate levels in children have previously been reported to be in the range of 60 to 440 pmol/L (36) , and a similar range is reported for adults (35) . The median plasma urate value for CF patients (330.8 pmol/L) was slightly above the mean value (270 pmol/L) previously observed in CF patients (37) . In the present study, some CF patients had urate levels markedly greater than the highest values reported by pmol/L) (37) . Elevated urate levels in urine and plasma have been previously reported in children with CF (38, 39) and have been attributed to the high purine content of the pancreatic enzyme supplements these children receive. In the current study, all the CF patients were receiving supplements of the pancreatic enzyme preparation Creon (Reid-Rowell, Marietta, GA). Increased plasma urate levels have also been indicated in children who are below normal height and weight for their age and who suffer repeated infections (36) , as is the case with CF children.
Mean plasma ascorbate levels in CF patients were 44% higher than in age-matched controls and were distributed over a range of 33 to 850 Fmol/L. Eleven of the 24 CF patients had plasma concentrations above the normal reported range, 1 1 to 100 pmol/ L (35) . This was also true of some (five of 20) of the controls. Two of the control subjects with high ascorbate concentrations were vegetarian. Dietary and vitamin supplement information was not available from control children, but was obtained retrospectively for six CF patients with the highest concentrations of ascorbate (data not shown). None of these patients was taking supplements or had dietary ascorbate intakes sufficient to explain his or her elevated plasma concentrations. Indeed, no clear relationship between ascorbate intake and plasma ascorbate levels was observed in these patients. The explanation for the high ascorbate levels in CF patients is thus obscure but may result from a reduced rate of clearance, an increased release, or slow uptake by the tissues, which are known to have higher ascorbate concentrations than plasma (34) .
Despite this increased antioxidant capacity, CF patients were found to have decreased TRAP,,,, compared with age-matched controls. This finding suggests that CF patients have a reduced capacity to withstand oxidative stress, such as that which they experience during periods of infection when activated phagocytes release free radicals as part of the respiratory burst. Indeed, there is already evidence that CF patients undergo oxidative stress. These include elevated markers of lipid peroxidation, an increase in intracellular antioxidant defenses (20) (21) (22) (23) , and a 100-to 1000-fold elevation in the number of neutrophils in the airways of the lung (25) . This increase in neutrophil numbers in the respiratory tract is likely to subject the airway to an extracellular oxidant stress (25) . Depressed extracellular glutathione concentrations in the lung have been linked to a number of pulmonary pathologies, including CF, idiopathic pulmonary fibrosis, smoking-related lung injury, and HIV infection (24, 40, 41) .
In summary, children with CF were found to have increased plasma concentrations of urate, sulfhydryl compounds and ascorbate, with vitamin E levels at the low end of the normal range. In spite of an increased array of extracellular scavenging antioxidants, CF patients were found to have a reduced total peroxyl trapping antioxidant potential. This appeared to be linked to their high ascorbate levels and may be attributable to the prooxidant activity of ascorbate. The study suggests that children with CF may have a reduced ability to withstand oxidative damage.
